Effectiveness, safety, and cost of vancomycin and linezolid in Kuwait: A retrospective cohort study

Effectiveness, safety, and cost of vancomycin and linezolid in Kuwait: A retrospective cohort study

Background: The effectiveness, safety, and cost of vancomycin and linezolid for managing gram-positive bacterial infections in Kuwait are unknown. This study assessed the effectiveness, safety, and cost of vancomycin, teicoplanin and linezolid for managing gram-positive bacterial infections in Kuwai...

Full description

Bibliographic Details
Main Authors:	Sarah S. Alghanem, Moetaza M. Soliman, Sarah Al-Manie, Wadha Alfouzan, Duaa Alhammadi, Yousif Alreshidi, Adnan Hajjiah, Rafaa Alfarhoud, Mai Almane, Mona Mataqi, Salma Alajmi, Khalifa Albenwan
Format:	Article
Language:	English
Published:	Elsevier 2023-11-01
Series:	Saudi Pharmaceutical Journal
Subjects:	Cost Linezolid Methicillin-resistant Staphylococcus aureus Teicoplanin Thrombocytopaenia Vancomycin
Online Access:	http://www.sciencedirect.com/science/article/pii/S1319016423003080

Similar Items

Dynamic Changes of Staphylococcus aureus Susceptibility to Vancomycin, Teicoplanin, and Linezolid in a Central Teaching Hospital in Shanghai, China, 2008–2018
by: Ying Jian, et al.
Published: (2020-05-01)

In Vitro Activity of Vancomycin, Teicoplanin, Linezolid and Daptomycin Against Methicillin-Resistant Staphylococcus aureus Isolates Collected from Chinese Hospitals in 2018–2020
by: Xu Y, et al.
Published: (2021-12-01)

Investigation of the Minimal Inhibitory Concentration Values of Vancomycin, Teicoplanin and Linezolid among MRSA Isolated from Inpatients by E-test Method
by: Tuğrul HOŞBUL, et al.
Published: (2012-06-01)

Epidemiology, treatment and outcomes of bloodstream infection due to vancomycin-resistant enterococci in cancer patients in a vanB endemic setting
by: Ouli Xie, et al.
Published: (2020-03-01)

Emergence of linezolid-resistance in vancomycin-resistant Enterococcus faecium ST117 associated with increased linezolid-consumption
by: Flaminia Olearo, et al.
Published: (2021-02-01)

Intravitreal linezolid in the management of vancomycin-resistant enterococcal endophthalmitis
by: Olufemi Emmanuel Babalola
Published: (2020-12-01)

Comparison of Different Phenotypic Methods Including E-test, Cefoxitin and Oxacillin Disk Diffusion for Detection of Methicillin Resistant Staphylococcus aureus
by: Geeta Gupta, et al.
Published: (2022-02-01)

Severe thrombocytopaenia in a patient after acute myocardial infarction with influenza
by: Katarzyna Barwinek, et al.
Published: (2023-12-01)

Activity of vancomycin combined with linezolid against clinical vancomycin-resistant Enterococcus strains
by: Gulseren Aktas
Published: (2020-07-01)

Risk factors for mortality after linezolid treatment of vancomycin-resistant Enterococcus bloodstream infection
by: Szu-Ting Huang, et al.
Published: (2023-04-01)

Alloimmune Thrombocytopaenic Disorders: A Review
by: Sophia Delicou, et al.
Published: (2015-03-01)

In vitro activity of vancomycin, quinupristin/dalfopristin, and linezolid against intact and disrupted biofilms of staphylococci
by: Kanchanapoom Termkiat, et al.
Published: (2005-01-01)

Uso de linezolid para el tratamiento de recién nacidos con infecciones por Enterococcus faecium resistentes a la vancomicina Linezolid for the treatment of newborns infected with vancomycin-resistant Enterococcus faecium
by: G. Berberian, et al.
Published: (2009-03-01)

Linezolid for the Treatment of Urinary Tract Infections Caused by Vancomycin-Resistant Enterococci
by: Mary Joyce Wingler, et al.
Published: (2021-10-01)

Treatment of bacteremia by vancomycin-resistant Enterococcus with daptomycin versus linezolid: a systematic review and meta-analyses
by: Caicedo-Ochoa, Edgar Yaset, et al.
Published: (2017-01-01)

Linezolid Resistance in Staphylococci
by: Stefania Stefani, et al.
Published: (2010-06-01)

Linezolid-induced serotonin syndrome
by: Anish Shouan, et al.
Published: (2020-01-01)

Comparative Study of Linezolid and Vancomycin Regimens in One-Stage Surgery for Treating Limb Traumatic Osteomyelitis Caused by Methicillin-Resistant Staphylococcus aureus
by: Zhou Rongchang, et al.
Published: (2023-09-01)

Linezolid-resistance Staphylococcus aureus – Prevalence, Emerging Resistance Mechanisms, Challenges and Perspectives
by: Hassan Rafique, et al.
Published: (2022-09-01)

Empiric use of linezolid in febrile hematology and hematopoietic stem cell transplantation patients colonized with vancomycin-resistant Enterococcus spp
by: Luiz F. Lisboa, et al.
Published: (2015-04-01)

Evaluation of Outcome of Pregnancy Complicated with Thrombocytopaenia- A Prospective Observational Study
by: Rao Bahadur Badugu, et al.
Published: (2022-12-01)

Linezolid and Vancomycin Resistant Enterococci: A Therapeutic Problem
by: Garima Yadav, et al.
Published: (2017-08-01)

Endocarditis due to vancomycin-resistant Enterococcus raffinosus successfully treated with linezolid: case report and review of literature Endocarditis por Enterococcus raffinosus resistente a vancomicina exitosamente tratada con linezolid: caso clínico y revisión de la literatura
by: A. Jasovich, et al.
Published: (2008-12-01)

Linezolid-induced pancytopenia and hyponatremia
by: Satish Kumar, et al.
Published: (2022-01-01)

Management of linezolid-induced peripheral neuropathy
by: Rituja Tambe, et al.
Published: (2023-01-01)

Fosfomycin Enhances the Inhibition Ability of Linezolid Against Biofilms of Vancomycin-Resistant Enterococcus faecium in vitro
by: Chi J, et al.
Published: (2023-12-01)

Clinical Pharmacology of Antimicrobials: Focus on the Safety of Vancomycin and Linezolid
by: M. V. Zhuravleva, et al.
Published: (2023-12-01)

Teicoplanin non-susceptible coagulase-negative staphylococci in a large Australian healthcare network: Implications for treatment with vancomycin
by: W. R. P. L. I. Wijesooriya, et al.
Published: (2017-05-01)

Stevens-Johnson Syndrome Following Vancomycin and Linezolid: A Real-World Analysis of Post-Marketing Surveillance Data
by: Ming Ni, et al.
Published: (2022-04-01)

Linezolid-resistant Enterococcus faecalis in leukemia patients: Rare cases with review of literature
by: Naveen Kumar, et al.
Published: (2019-01-01)

Incidence of teicoplanin adverse drug reactions among patients with vancomycin-associated adverse drug reactions and its risk factors
by: Byung-Keun Kim, et al.
Published: (2020-05-01)

A Nanoplex PCR Assay for the Simultaneous Detection of Vancomycin- and Linezolid-Resistant Genes in <i>Enterococcus</i>
by: Yusuf Wada, et al.
Published: (2023-02-01)

Emergence of linezolid- and vancomycin-resistant Enterococcus faecium in a department for hematologic stem cell transplantation
by: M. Krull, et al.
Published: (2016-09-01)

Comparative efficacy of linezolid and vancomycin for endotracheal tube MRSA biofilms from ICU patients
by: Laia Fernández-Barat, et al.
Published: (2019-07-01)

Cost-effectiveness of linezolid versus vancomycin in mechanical ventilation-associated nosocomial pneumonia caused by methicillin-resistant staphylococcus aureus
by: Adão R. L. Machado, et al.

Pharmacodynamics Of Linezolid-Plus-Fosfomycin Against Vancomycin-Susceptible And -Resistant Enterococci In Vitro And In Vivo Of A Galleria mellonella Larval Infection Model
by: Qi C, et al.
Published: (2019-11-01)

Low Rate of Acquired Linezolid Resistance in Multidrug-Resistant Tuberculosis Treated With Bedaquiline-Linezolid Combination
by: Jian Du, et al.
Published: (2021-05-01)

The Properties of Linezolid, Rifampicin, and Vancomycin, as Well as the Mechanism of Action of Pentamidine, Determine Their Synergy against Gram-Negative Bacteria
by: Miran Tang, et al.
Published: (2023-09-01)

Linezolid drug interactions: A retrospective study
by: Zeynep Ulku Gun, et al.
Published: (2020-06-01)

In vitro antibacterial effects of Tanreqing injection combined with vancomycin or linezolid against methicillin-resistant Staphylococcus aureus
by: Weifeng Yang, et al.
Published: (2018-05-01)